SGAM
Smith Group Asset Management Portfolio holdings
AUM
$1.53B
1-Year Return
38.67%
This Quarter Return
+2.93%
1 Year Return
+38.67%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$3.42B
AUM Growth
+$6M
(+0.18%)
Cap. Flow
-$61M
Cap. Flow
% of AUM
-1.78%
Top 10 Holdings %
Top 10 Hldgs %
23.69%
Holding
516
New
65
Increased
98
Reduced
233
Closed
68
Top Buys
| 1 |
Target
TGT
|
$65.3M |
| 2 |
Thor Industries
THO
|
$38.3M |
| 3 |
Lear
LEA
|
$35.2M |
| 4 |
Las Vegas Sands
LVS
|
$34.5M |
| 5 |
Idexx Laboratories
IDXX
|
$33.7M |
Top Sells
| 1 |
Campbell Soup
CPB
|
$60.2M |
| 2 |
Lowe's Companies
LOW
|
$57.7M |
| 3 |
Clorox
CLX
|
$45.9M |
| 4 |
Darden Restaurants
DRI
|
$39.4M |
| 5 |
DISH
DISH Network Corp.
DISH
|
$37.6M |
Sector Composition
| 1 | Technology | 17.23% |
| 2 | Consumer Discretionary | 16.47% |
| 3 | Healthcare | 16.3% |
| 4 | Industrials | 12.96% |
| 5 | Consumer Staples | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Ormat Technologies
ORA
$5.51B
| $616K | 0.02% |
+11,480
| New | +$616K |
|
177
Dorman Products
DORM
$5B
| $611K | 0.02% |
8,360
-100
| -1% | -$7.31K |
|
178
Ultragenyx Pharmaceutical
RARE
$3.07B
| $609K | 0.02% |
8,660
-100
| -1% | -$7.03K |
|
179
First Community Bankshares
FCBC
$688M
| $573K | 0.02% |
19,000
-913
| -5% | -$27.5K |
|
180
World Acceptance Corp
WRLD
$942M
| $550K | 0.02% |
8,560
-490
| -5% | -$31.5K |
|
|
BSTC
181
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $545K | 0.02% |
9,788
-300
| -3% | -$16.7K |
|
182
Stock Yards Bancorp
SYBT
$2.34B
| $532K | 0.02% |
11,335
-360
| -3% | -$16.9K |
|
183
Archrock
AROC
$4.44B
| $523K | 0.02% |
39,610
-7,650
| -16% | -$101K |
|
184
Ezcorp Inc
EZPW
$1.02B
| $515K | 0.02% |
48,310
-10,120
| -17% | -$108K |
|
185
Molina Healthcare
MOH
$9.47B
| $508K | 0.01% |
9,360
+900
| +11% | +$48.8K |
|
186
REX American Resources
REX
$1.02B
| $498K | 0.01% |
15,120
-480
| -3% | -$15.8K |
|
187
First Financial Corporation Common Stock
THFF
$695M
| $488K | 0.01% |
9,250
-63,513
| -87% | -$3.35M |
|
188
Interparfums
IPAR
$3.63B
| $485K | 0.01% |
+14,800
| New | +$485K |
|
189
Tilly's
TLYS
$57.3M
| $471K | 0.01% |
35,690
+17,000
| +91% | +$224K |
|
190
Pathward Financial
CASH
$1.74B
| $466K | 0.01% |
+13,590
| New | +$466K |
|
191
US Physical Therapy
USPH
$1.3B
| $466K | 0.01% |
6,637
-1,790
| -21% | -$126K |
|
|
ARC
192
DELISTED
ARC Document Solutions, Inc.
ARC
| $460K | 0.01% |
90,610
-2,910
| -3% | -$14.8K |
|
|
ARIA
193
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $451K | 0.01% |
36,250
| – | – |
|
194
Arrow Financial
AROW
$483M
| $446K | 0.01% |
13,553
-443
| -3% | -$14.6K |
|
195
Exelixis
EXEL
$10.2B
| $439K | 0.01% |
29,410
| – | – |
|
|
BELFB
196
Bel Fuse Class B
BELFB
$1.82B
| $437K | 0.01% |
14,150
-520
| -4% | -$16.1K |
|
197
Ironwood Pharmaceuticals
IRWD
$188M
| $437K | 0.01% |
34,148
| – | – |
|
198
OFG Bancorp
OFG
$1.99B
| $403K | 0.01% |
+30,740
| New | +$403K |
|
199
Ennis
EBF
$476M
| $401K | 0.01% |
23,109
+21,920
| +1,844% | +$380K |
|
200
Ligand Pharmaceuticals
LGND
$3.25B
| $399K | 0.01% |
6,300
| – | – |
|